|
Market Closed -
Euronext Bruxelles
11:55:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 291.30 EUR | -1.09% |
|
+3.08% | +22.09% |
| 11-09 | UCB Announces Week 24 Data For BIMZELX Bimekizumab-Bkzx From BE BOLD Study | CI |
| 11-09 | UCB And Biogen Announce Clinical Profile Data For Dapirolizumab Pegol In Systemic Lupus Erythematosus | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.09% | +3.08% | +43.14% | +28.78% | +22.09% | +28.38% | +342.84% | +171.36% | +353.81% | 62.61B | |
| +0.35% | +1.36% | +21.88% | +18.29% | +33.74% | +45.38% | +140.47% | +447.27% | +1,750.51% | 1,276B | |
| -0.13% | +1.48% | +7.26% | +7.93% | +35.50% | +44.67% | +90.43% | +71.97% | +136.69% | 676B | |
| +0.37% | +0.05% | +6.70% | +17.95% | +29.10% | +31.00% | +112.84% | +152.92% | +367.48% | 519B | |
| +0.02% | +1.52% | +12.33% | +8.95% | +22.46% | +39.21% | +69.76% | +8.52% | +71.39% | 388B | |
| -0.59% | -2.11% | +1.09% | +12.85% | +39.83% | +61.83% | +45.16% | +75.17% | +130.15% | 365B | |
| -1.29% | -1.13% | +11.45% | +5.47% | +21.11% | +27.54% | +58.29% | +74.25% | +83.09% | 307B | |
| +0.09% | -0.91% | +15.82% | +17.33% | +0.77% | +3.19% | +37.72% | +47.14% | +221.22% | 287B | |
| +0.62% | -2.17% | +12.83% | +12.99% | +43.02% | +38.31% | +75.12% | +121.27% | +214.08% | 252B | |
| -0.67% | -2.72% | +12.28% | +25.01% | +38.28% | +38.49% | +123.56% | +151.71% | +122.10% | 212B | |
| +0.44% | -4.38% | +6.84% | -11.23% | -16.16% | -13.06% | -60.57% | -25.94% | +138.69% | 179B | |
| +0.31% | -4.35% | +4.14% | +10.63% | +18.27% | +15.44% | -0.10% | -41.31% | -9.63% | 167B | |
| -0.16% | -0.37% | +7.24% | +3.28% | +20.66% | +27.45% | +46.40% | +194.31% | +494.60% | 139B | |
| +0.18% | -1.99% | +6.41% | -1.10% | +16.63% | +29.13% | +24.30% | +6.28% | +11.60% | 128B | |
| -0.26% | +0.97% | +15.01% | +19.74% | +31.64% | +26.08% | +130.09% | +384.51% | +654.94% | 125B | |
| +0.77% | +2.98% | +21.10% | +14.87% | +4.70% | -2.74% | +1.73% | -3.65% | +13.86% | 115B | |
| -1.56% | -0.16% | +7.83% | -0.47% | +3.43% | +3.43% | +34.94% | -5.04% | -1.62% | 102B | |
| -0.85% | -3.75% | +10.53% | +310.58% | +743.30% | +841.65% | +255.02% | +10.13% | - | 101B | |
| +4.73% | +3.09% | +28.51% | +20.38% | +24.30% | +42.23% | +20.09% | +53.10% | +128.55% | 91.92B | |
| +0.17% | -0.45% | +16.01% | -0.36% | -13.16% | -8.82% | +51.65% | +73.82% | +551.71% | 74.2B | |
| Average | +0.09% | +0.34% | +13.42% | +26.09% | +55.97% | +65.94% | +79.99% | +98.39% | +285.96% | 278B | |
| Weighted average by Cap. | +0.39% | +0.48% | +12.89% | +18.10% | +39.36% | +48.62% | +87.67% | +164.14% | +551.01% |
- Stock Market
- Stocks
- UCB Stock
- Sector UCB
Select your edition
All financial news and data tailored to specific country editions
